New discovery may offer a promising avenue for study of multiple sclerosis

A surprising discovery may offer a promising new direction in the study of multiple sclerosis and other diseases of hypomyelination – when axons of neurons are not covered sufficiently in fatty sheaths (myelin), which disrupts communication between nerve cells.

While investigating potential mechanisms of brain tumor formation, Oren Becher, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, and colleagues, found that overexpression of a growth factor receptor (called PDGFRA) in a mouse model did not cause tumors, as anticipated. Instead, they observed severe hypomyelination, which manifested as impaired balance, and hindlimb and tail tremors. Their findings were published in the journal Brain and Behavior.

"Our study provides a new model for studying hypomyelination," said Dr. Becher, senior author on the study, Rory David Deutsch Malignant Brain Tumor Research Scholar at Lurie Children's and Associate Professor of Pediatrics, Biochemistry and Molecular Genetics at Northwestern University Feinberg School of Medicine. "Blocking this receptor might prove to be a novel strategy to treat myelination disorders like multiple sclerosis. Of course, more research is needed to confirm our results and explore further."

Dr. Becher pointed out that the current study focused on prenatal events, which might explain why no tumors were formed, since timing is very important in cancer development.

We saw that too much PDGFRA interfered with differentiation of progenitor cells that give rise to cells that make myelin. These progenitor cells, which continue to be generated throughout the human lifespan, are known to be the cell of origin for brain tumors like diffuse midline glioma. Our findings suggest that the mechanisms we observed might spur brain tumor development at a postnatal stage. I would like to express my profound gratitude to the Rory David Deutsch Foundation and Lurie Children's for their vision, confidence and support of this research," said Dr. Becher.

Dr. Oren Becher, MD, Ann & Robert H. Lurie Children's Hospital of Chicago

Source:
Journal reference:

Cardona, H.J., et al. (2021) Prenatal overexpression of platelet‐derived growth factor receptor A results in central nervous system hypomyelination. Brain and Behavior. doi.org/10.1002/brb3.2332.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Covid-19 may raise risk of developing multiple sclerosis